An oral version of the GLP-1 drug semaglutide failed to significantly slow the disease’s progression compared to...
GLP-1s
Auto Added by WPeMatico
New research suggests that people taking GLP-1 therapy are less likely to die from colorectal cancer.
Preliminary research suggests that NG101, a drug from Neurogastrx, may lower the risk of nausea and vomiting...
A new analysis finds that the heart-protecting benefits of semaglutide are largely independent of its weight loss...
New research shows that substantially more Americans would qualify as being obese using new diagnostic criteria released...
Semaglutide and tirzepatide are among 20 new additions to the WHO’s list of essential medicines.
In new Phase III trial data released Tuesday, people taking orforglipron lost substantially more weight than people...
